Danusertib

• Description :

  A potent, ATP-competitive Aurora kinase inhibitor with IC50 of 13,79 and 61 nM for Aurora A, B and C, respectively; Also inhibits Abl, RET, and FGFR1 (IC50=25,31, and 47 nM) .

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  474.5548

• Molecular Formula :

  C26H30N6O3

• Notes :

  Research use only, not for human use.

• Receptor :

  Abl|AuroraA|AuroraB|AuroraC|FGFR1|RET|TrkA

• CAS Number :

  827318-97-8